Diabetes Mellitus: Molecular Mechanisms, Genetics and New Therapies
joint with Molecular Control of Adipogenesis and Obesity
Organizer(s): Alan R. Saltiel and C. Ronald KahnDate: January 10 - 16, 2002
Location: Keystone Resort, Keystone, CO, USA
Our understanding of the pathogenesis of diabetes mellitus is advancing at a rapid pace. New insights are emerging in the areas of insulin signaling, genetics, metabolic regulation, beta cell function and development, and interplay between organ systems. These developments are leading to new advances in the diagnosis of individuals at risk for diabetes, as well as in the treatment of the disease and its complications. The goal of this conference (in conjunction with the Molecular Control of Adipogenesis and Obesity symposium organized by Speigelman and Friedman) will be to identify the most exciting areas of research, look for common themes among scientists exploring basic approaches to hormone action and secretion, genetics and therapeutics. Areas of particular interest will include the identification and analyses of new phosphorylation cascades, negative regulation of signaling, genes and processes involved in beta cell development, complex interactions between tissues in the metabolic staging of diabetes, regulation of gene expression, especially using new technologies in functional genomics, and issues concerning the central regulation of energy expenditure and glucose metabolism. Most of these topics will interface with the proposed concurrent meeting on adipogenesis, so that we can share sessions, and explore the complex interactions between obesity and diabetes.
Discounted Abstract Deadline: October 1 2001
Discounted Registration Deadline: November 12 2001
We gratefully acknowledge additional support for this conference from: